{"id":5976,"date":"2012-12-11T15:41:00","date_gmt":"2012-12-11T06:41:00","guid":{"rendered":"https:\/\/www.iir.hit-u.ac.jp\/en\/2012\/12\/11\/research-administrators\/"},"modified":"2012-12-11T15:41:00","modified_gmt":"2012-12-11T06:41:00","slug":"research-administrators","status":"publish","type":"post","link":"https:\/\/www.iir.hit-u.ac.jp\/en\/2012\/12\/11\/research-administrators\/","title":{"rendered":"Research Administrators"},"content":{"rendered":"

<\/p>\n

\u25a0<\/span> Research Administrators<\/span><\/div>\n
<\/div>\n
\u25a0<\/span> Full-time faculty members of the Institute of Innovation Research<\/span><\/div>\n
\u3000<\/span><\/span><\/div>\n
\u25a0<\/span> Visiting Professor<\/span><\/div>\n
\u3000<\/span> Dr. Endo Akira<\/span><\/div>\n
\u3000<\/span> IIR invited Dr. Endo Akira to join the faculty as a visiting professor in November 2009. Dr. Endo was a pioneer in the discovery and development of a series of new drug groups called statins, which are being taken by over 30 million people around the world each day as an effective medication for dyslipidemia (high blood cholesterol levels), one of the causes of arteriosclerosis and heart disease. For his work, Dr. Endo was awarded The Lasker Medical Research Award, a highly prestigious international honor, in 2008. As a key figure in the research under this program, Dr. Endo is engaged in research in the biotechnology and life sciences sector in cooperation with the Japan Pharmaceutical Manufacturers Association\u2019s Office of Pharmaceutical Industry Research and the Japan Bioindustry Association. In addition to his research, he is newly participating in the research being conducted by IIR with a focus on researchers. The purpose is to gain implications for the best approach to management, and determine the optimal methodologies for Japan\u2019s system, in sectors where science will play a critical role in the future.<\/span><\/div>\n
\u3000<\/span><\/span><\/div>\n
\u25a0<\/span> Adjunct Professors and Associate Professors<\/span><\/div>\n
\u3000\u3000<\/span>Igami Masatsura<\/span><\/div>\n
\u3000\u3000<\/span>Ito Satoru<\/span><\/div>\n
\u3000\u3000<\/span>Ohsugi Yoshiyuki<\/span><\/div>\n
\u3000\u3000<\/span>Osada Toshihiko (FY2008 – 2009)<\/span><\/div>\n
\u3000\u3000<\/span>Kameyama Masaomi (FY2008 – 2009) (FY2012 – present)<\/span><\/div>\n
\u3000\u3000<\/span>Nakaya Masao<\/span><\/div>\n
\u3000\u3000<\/span>Tokoro Gensuke<\/span><\/div>\n
\u3000<\/span> \u3000<\/span> (In order of Japanese syllabary)<\/span><\/div>\n
\u3000<\/span><\/span><\/div>\n
\u25a0<\/span> Industry-academia-government collaboration researchers<\/span><\/div>\n
\u3000\u3000<\/span>Yusuke Naito<\/span><\/div>\n
\u3000<\/span><\/span><\/div>\n
\u25a0<\/span> Adjunct researchers<\/span><\/div>\n
\u3000\u3000<\/span>Ijichi Tomohiro           (Professor, Faculty of Innovation Studies, Seijo University)<\/span><\/div>\n
\u3000\u3000<\/span>Owan Hideo               (Professor, Institute of Social Science, The University of Tokyo)<\/span><\/div>\n
\u3000\u3000<\/span>Tsuno Katsushige      (Electron Optics Solutions)<\/span><\/div>\n
\u3000\u3000<\/span>Nakamura Kenta       (Associate Professor, Graduate School of Economics, Kobe University)<\/span><\/div>\n
\u3000\u3000<\/span>Honjo Yuji                   (Professor, Faculty of Commerce, Chuo University)<\/span><\/div>\n
\u3000\u3000<\/span>Setsuo Morishita       (Japan Bioindustry Association, FY2008)<\/span><\/div>\n
\u3000<\/span> \u3000<\/span> (In order of Japanese syllabary)<\/span><\/div>\n
\u3000<\/span><\/span><\/div>\n
\u25a0<\/span> Researchers<\/span><\/div>\n
\u3000\u3000<\/span>Tsukada Naotoshi (FY2008-2010)<\/span><\/div>\n
\u3000<\/span>  Nishimura Junichi<\/span><\/div>\n","protected":false},"excerpt":{"rendered":"

\u25a0 Research Administrators \u25a0 Full-time faculty members of the Institute of Innovation Research \u3000 \u25a0 Visiting Professor \u3000 Dr. Endo Akira \u3000 IIR invited Dr. Endo Akira to join the faculty as a visiting professor in November 2009. Dr. Endo was a pioneer in the discovery and development of a series of new drug groups called statins, which are being taken by over 30 million people around the world each day as an effective medication for dyslipidemia (high blood cholesterol levels), one of the causes of arteriosclerosis and heart disease. For his work, Dr. Endo was awarded The Lasker Medical Research Award, a highly prestigious international honor, in 2008. As…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"sns_share_botton_hide":"","vkExUnit_sns_title":"","_vk_print_noindex":"","sitemap_hide":"","_veu_custom_css":"","veu_display_promotion_alert":"","vkexunit_cta_each_option":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-5976","post","type-post","status-publish","format-standard","hentry","category-i-g-a-collaboration"],"veu_head_title_object":{"title":"","add_site_title":""},"_links":{"self":[{"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/posts\/5976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/comments?post=5976"}],"version-history":[{"count":0,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/posts\/5976\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/media?parent=5976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/categories?post=5976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iir.hit-u.ac.jp\/en\/wp-json\/wp\/v2\/tags?post=5976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}